Carlo Cattrini
16PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Apr 27, 2024
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.Sara Mokbel, Giuilia Baciarello, Pernelle Lavaud
|Apr 19, 2024
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients.Sebastiano Buti, Alessandro Olivari, Cristina Masini
|Jul 26, 2023
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study.Chiara Tommasi, Giulia Scartabellati, Diana Giannarelli
|Apr 12, 2022
Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review.Carlo Cattrini, Orazio Caffo, Ugo De Giorgi
|Nov 22, 2021
Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysis.Sebastiano Buti, Melissa Bersanelli, Giulia Mazzaschi
|Nov 04, 2021
Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis.Carlo Cattrini, Carlo Messina, Chiara Airoldi
Pageof 3
Frequent Collaborators
5 joint publications
Melissa Bersanelli
3 joint publications
Elena Castro
3 joint publications
Sebastiano Buti
2 joint publications
Paola Barboro
2 joint publications
Carlo Messina
1 joint publications
Elisa Zanardi
1 joint publications
Giacomo Vallome
1 joint publications
Davide Soldato
1 joint publications
Vincenzo Formica
1 joint publications
Paolo Marzullo
